Variant report
Variant | esv2158567 |
---|---|
Chromosome Location | chr13:51173414-51173820 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556918516 | chr13:51173423-51173424 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs78609478 | chr13:51173452-51173453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114600381 | chr13:51173483-51173484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569633438 | chr13:51173490-51173491 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536922446 | chr13:51173492-51173493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138849213 | chr13:51173508-51173509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183859171 | chr13:51173516-51173517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs187410071 | chr13:51173575-51173576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35635062 | chr13:51173584-51173585 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76082065 | chr13:51173601-51173602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs202110459 | chr13:51173602-51173603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200454510 | chr13:51173603-51173604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201141877 | chr13:51173604-51173605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112841954 | chr13:51173644-51173645 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553079825 | chr13:51173650-51173651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149340502 | chr13:51173718-51173719 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570392241 | chr13:51173727-51173728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190627205 | chr13:51173730-51173731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs475883 | chr13:51173732-51173733 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs116350959 | chr13:51173737-51173738 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143657608 | chr13:51173738-51173739 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560339631 | chr13:51173742-51173743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115631720 | chr13:51173763-51173764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs117280701 | chr13:51173793-51173794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs74078107 | chr13:51173800-51173801 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs6561585 | chr13:51173811-51173812 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Mental retardation | 17502991 | CNVD |
Retinoblastoma | 17502991 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Liposarcoma | 21253554 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cervical cancer | 21062161 | CNVD |
microdeletion syndrome | 19284877 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hereditary prostate cancer | 22028916 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Prostate cancer | 17217626 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21990379 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:51160200-51174000 | Enhancers | Primary B cells from peripheral blood | blood |
2 | chr13:51168000-51174000 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr13:51168000-51174400 | Enhancers | Fetal Thymus | thymus |
4 | chr13:51168400-51174000 | Enhancers | Left Ventricle | heart |
5 | chr13:51168800-51173800 | Enhancers | Adipose Nuclei | Adipose |
6 | chr13:51169000-51174400 | Enhancers | Fetal Heart | heart |
7 | chr13:51169200-51174000 | Enhancers | Primary B cells from cord blood | blood |
8 | chr13:51169200-51174000 | Enhancers | Thymus | Thymus |
9 | chr13:51169200-51174200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
10 | chr13:51169200-51174800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr13:51169800-51174600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
12 | chr13:51169800-51175000 | Enhancers | Dnd41 | blood |
13 | chr13:51171600-51174800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr13:51172600-51173800 | Enhancers | Fetal Stomach | stomach |
15 | chr13:51172600-51174600 | Enhancers | K562 | blood |
16 | chr13:51173000-51174800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr13:51173200-51173600 | Enhancers | Fetal Lung | lung |
18 | chr13:51173400-51177000 | Weak transcription | Right Ventricle | heart |